Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
|
In millions, except per share items | Dec-30-22 | Dec-31-21 | Jan-01-21 | Jan-03-20 | Dec-28-18 | Dec-29-17 | Dec-30-16 | Jan-01-16 |
| 8-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 8-K |
Revenues: |
Defense Solutions | | 8,032 | 7,341 | 6,300 | 5,778 | 4,989 | | |
Civil | | 3,157 | 2,994 | 2,796 | 2,599 | 3,379 | | |
Health | | 2,548 | 1,962 | 1,998 | 1,817 | 1,802 | | |
Other | | 40,851 | 36,591 | 32,928 | | | | |
Total revenues | 14,396 | 54,588 | 48,888 | 44,022 | 10,194 | 10,170 | 6,936 | 5,086 |
Revenue growth [+] | -73.6% | 11.7% | 11.1% | 331.8% | 0.2% | 46.6% | 36.4% | |
Defense Solutions | | 9.4% | 16.5% | 9.0% | 15.8% | | | |
Civil | | 5.4% | 7.1% | 7.6% | -23.1% | | | |
Health | | 29.9% | -1.8% | 10.0% | 0.8% | | | |
Cost of goods sold | 12,312 | 11,723 | 10,560 | 9,546 | 8,690 | 8,738 | 6,103 | 4,468 |
Gross profit | 2,084 | 42,865 | 38,328 | 34,476 | 1,504 | 1,432 | 833 | 618 |
Gross margin | 14.5% | 78.5% | 78.4% | 78.3% | 14.8% | 14.1% | 12.0% | 12.2% |
Selling, general and administrative | 950 | 860 | 770 | 689 | 729 | 737 | 422 | 232 |
Equity in earnings | 12 | -20 | -14 | -18 | -18 | -13 | -10 | |
Other operating expenses | 6 | 40,849 | 36,548 | 32,875 | 19 | 136 | -10 | 9 |
EBITDA [+] | 1,473 | 1,481 | 1,292 | 1,146 | 1,013 | 895 | 543 | 421 |
EBITDA growth | -0.5% | 14.6% | 12.7% | 13.1% | 13.2% | 64.8% | 29.0% | |
EBITDA margin | 10.2% | 2.7% | 2.6% | 2.6% | 9.9% | 8.8% | 7.8% | 8.3% |
Depreciation | 333 | 97 | 84 | 61 | 56 | 55 | 38 | 44 |
EBITA | 1,140 | 1,384 | 1,208 | 1,085 | 957 | 840 | 505 | 377 |
EBITA margin | 7.9% | 2.5% | 2.5% | 2.5% | 9.4% | 8.3% | 7.3% | 7.4% |
Amortization of intangibles | | 228 | 198 | 173 | 201 | 281 | 84 | |
EBIT [+] | 1,140 | 1,156 | 1,010 | 912 | 756 | 559 | 421 | 377 |
EBIT growth | -1.4% | 14.5% | 10.7% | 20.6% | 35.2% | 32.8% | 11.7% | |
EBIT margin | 7.9% | 2.1% | 2.1% | 2.1% | 7.4% | 5.5% | 6.1% | 7.4% |
Non-recurring items [+] | 40 | 4 | 12 | | 7 | | 4 | 79 |
Asset impairment | 40 | 4 | 12 | | 7 | | 4 | 73 |
Restructuring charges | | | | | | | | 6 |
Interest expense, net [+] | 199 | 184 | 179 | 133 | 138 | 140 | 86 | -4 |
Interest expense | 199 | 185 | 182 | 147 | 145 | 148 | 96 | |
Interest income | | 1 | 3 | 14 | 7 | 8 | 10 | 4 |
Other income (expense), net | -15 | -1 | -38 | 87 | -1 | -26 | -13 | 26 |
Pre-tax income | 886 | 967 | 781 | 866 | 610 | 393 | 318 | 328 |
Income taxes | 193 | 208 | 152 | 196 | 28 | 29 | 72 | 92 |
Tax rate | 21.8% | 21.5% | 19.5% | 22.6% | 4.6% | 7.4% | 22.6% | 28.0% |
Minority interest | | 6 | 1 | 3 | 1 | -2 | 2 | |
Earnings from continuing ops | 693 | 753 | 628 | 667 | 581 | 366 | 244 | 236 |
Earnings from discontinued ops | | | | | | | | 0 |
Net income | 693 | 753 | 628 | 667 | 581 | 366 | 244 | 254 |
Net margin | 4.8% | 1.4% | 1.3% | 1.5% | 5.7% | 3.6% | 3.5% | 5.0% |
|
Basic EPS [+] | $5.06 | $5.34 | $4.42 | $4.66 | $3.85 | $2.41 | $2.39 | $3.23 |
Growth | -5.3% | 20.8% | -5.2% | 21.2% | 59.8% | 0.7% | -26.0% | |
Diluted EPS [+] | $5.02 | $5.27 | $4.36 | $4.60 | $3.80 | $2.38 | $2.35 | $3.19 |
Growth | -4.6% | 20.7% | -5.2% | 21.1% | 59.8% | 1.3% | -26.4% | |
|
Dividends per share [+] | $1,440,000.00 | $1.40 | $1.36 | $1.32 | $1.28 | $1.28 | $1.28 | $1,280,000.00 |
Growth | 102857042.9% | 2.9% | 3.0% | 3.1% | 0.0% | 0.0% | -100.0% | |
|
Shares outstanding (basic) [+] | 137 | 141 | 142 | 143 | 151 | 152 | 102 | 73 |
Growth | -2.8% | -0.7% | -0.7% | -5.3% | -0.7% | 49.0% | 39.7% | |
Shares outstanding (diluted) [+] | 138 | 143 | 144 | 145 | 153 | 154 | 104 | 74 |
Growth | -3.5% | -0.7% | -0.7% | -5.2% | -0.6% | 48.1% | 40.5% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|